Unhealthy Days and Quality of Life in Irish Patients with Diabetes

Typeset version

 

TY  - JOUR
  - Clifford, EL,Collins, MM,Buckley, CM,Fitzgerald, AP,Perry, IJ
  - 2013
  - December
  - Plos One
  - Unhealthy Days and Quality of Life in Irish Patients with Diabetes
  - Validated
  - Altmetric: 2 ()
  - HEALTH-STATUS US ADULTS INSTRUMENTS SURVEILLANCE MELLITUS HABITS ADDQOL
  - 8
  - Objectives: To study the determinants of health-related quality of life (HRQoL) in Irish patients with diabetes using the Centres for Disease Controls' (CDC's) 'Unhealthy Days' summary measure and to assesses the agreement between this generic HRQoL measure and the disease-specific Audit of Diabetes Dependant Quality of Life (ADDQoL) measure.Research Design and Methods: Data were analysed from the Diabetes Quality of Life Study, a cross-sectional study of 1,456 people with diabetes in Ireland (71% response rate). Unhealthy days were assessed using the CDC's 'Unhealthy days' summary measure. Quality of life (QoL) was also assessed using the ADDQoL measure. Analyses were conducted primarily using logistic regression. The agreement between the two QoL instruments was measured using the kappa co-efficient.Results: Participants reported a median of 2 unhealthy days per month. In multivariate analyses, female gender (P = 0.001), insulin use (P = 0.030), diabetes complications (P =<0.001) were significantly associated with more unhealthy days. Older patients had fewer unhealthy days per month (P = 0.003). Agreement between the two measures of QoL (unhealthy days measure and ADDQoL) was poor, Kappa = 0.234Conclusions: The findings highlight the determinants of HRQoL in patients with diabetes using a generic HRQoL summary measure. The 'Unhealthy Days' and the ADDQoL have poor agreement, therefore the 'Unhealthy Days' summary measure may be assessing a different construct. Nonetheless, this study demonstrates that the generic 'Unhealthy Days' summary measure can be used to detect determinants of HRQoL in patients with diabetes.
  - 10.1371/journal.pone.0081102
DA  - 2013/12
ER  - 
@article{V243938901,
   = {Clifford,  EL and Collins,  MM and Buckley,  CM and Fitzgerald,  AP and Perry,  IJ },
   = {2013},
   = {December},
   = {Plos One},
   = {Unhealthy Days and Quality of Life in Irish Patients with Diabetes},
   = {Validated},
   = {Altmetric: 2 ()},
   = {HEALTH-STATUS US ADULTS INSTRUMENTS SURVEILLANCE MELLITUS HABITS ADDQOL},
   = {8},
   = {{Objectives: To study the determinants of health-related quality of life (HRQoL) in Irish patients with diabetes using the Centres for Disease Controls' (CDC's) 'Unhealthy Days' summary measure and to assesses the agreement between this generic HRQoL measure and the disease-specific Audit of Diabetes Dependant Quality of Life (ADDQoL) measure.Research Design and Methods: Data were analysed from the Diabetes Quality of Life Study, a cross-sectional study of 1,456 people with diabetes in Ireland (71% response rate). Unhealthy days were assessed using the CDC's 'Unhealthy days' summary measure. Quality of life (QoL) was also assessed using the ADDQoL measure. Analyses were conducted primarily using logistic regression. The agreement between the two QoL instruments was measured using the kappa co-efficient.Results: Participants reported a median of 2 unhealthy days per month. In multivariate analyses, female gender (P = 0.001), insulin use (P = 0.030), diabetes complications (P =<0.001) were significantly associated with more unhealthy days. Older patients had fewer unhealthy days per month (P = 0.003). Agreement between the two measures of QoL (unhealthy days measure and ADDQoL) was poor, Kappa = 0.234Conclusions: The findings highlight the determinants of HRQoL in patients with diabetes using a generic HRQoL summary measure. The 'Unhealthy Days' and the ADDQoL have poor agreement, therefore the 'Unhealthy Days' summary measure may be assessing a different construct. Nonetheless, this study demonstrates that the generic 'Unhealthy Days' summary measure can be used to detect determinants of HRQoL in patients with diabetes.}},
   = {10.1371/journal.pone.0081102},
  source = {IRIS}
}
AUTHORSClifford, EL,Collins, MM,Buckley, CM,Fitzgerald, AP,Perry, IJ
YEAR2013
MONTHDecember
JOURNAL_CODEPlos One
TITLEUnhealthy Days and Quality of Life in Irish Patients with Diabetes
STATUSValidated
TIMES_CITEDAltmetric: 2 ()
SEARCH_KEYWORDHEALTH-STATUS US ADULTS INSTRUMENTS SURVEILLANCE MELLITUS HABITS ADDQOL
VOLUME8
ISSUE
START_PAGE
END_PAGE
ABSTRACTObjectives: To study the determinants of health-related quality of life (HRQoL) in Irish patients with diabetes using the Centres for Disease Controls' (CDC's) 'Unhealthy Days' summary measure and to assesses the agreement between this generic HRQoL measure and the disease-specific Audit of Diabetes Dependant Quality of Life (ADDQoL) measure.Research Design and Methods: Data were analysed from the Diabetes Quality of Life Study, a cross-sectional study of 1,456 people with diabetes in Ireland (71% response rate). Unhealthy days were assessed using the CDC's 'Unhealthy days' summary measure. Quality of life (QoL) was also assessed using the ADDQoL measure. Analyses were conducted primarily using logistic regression. The agreement between the two QoL instruments was measured using the kappa co-efficient.Results: Participants reported a median of 2 unhealthy days per month. In multivariate analyses, female gender (P = 0.001), insulin use (P = 0.030), diabetes complications (P =<0.001) were significantly associated with more unhealthy days. Older patients had fewer unhealthy days per month (P = 0.003). Agreement between the two measures of QoL (unhealthy days measure and ADDQoL) was poor, Kappa = 0.234Conclusions: The findings highlight the determinants of HRQoL in patients with diabetes using a generic HRQoL summary measure. The 'Unhealthy Days' and the ADDQoL have poor agreement, therefore the 'Unhealthy Days' summary measure may be assessing a different construct. Nonetheless, this study demonstrates that the generic 'Unhealthy Days' summary measure can be used to detect determinants of HRQoL in patients with diabetes.
PUBLISHER_LOCATION
ISBN_ISSN
EDITION
URL
DOI_LINK10.1371/journal.pone.0081102
FUNDING_BODY
GRANT_DETAILS